Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease

por Kaloyannidis, Panayotis, Shaibani, Eshrak Al, Apostolidis, Ioannis, Kanfar, Solaf, Anezi, Khalid Al, Hashmi, Hani Al
Publicado 2018

ANTIBODY RESPONSES AND SAFETY OF THE COMMERCIALLY AVAILABLE VACCINES AGAINST SARS-COV-2 VIRUS IN ALLOGRAFTED PATIENTS: REAL WORLD DATA FROM A SINGLE CENTER

por Kaloyannidis, Panayotis, Blowi, Belal, Yahya, Rana, Khaldi, Hamdah Al, Attas, Rabab, Dayel, Afra, Kanfar, Solaf
Publicado 2022

Saudi Arabian CML patient with a novel four‐way translocation at t(9;22;5;2)(q34;q11.2;p13;q44)

por Dridi, Walid, Kanfar, Solaf, Sleiman, Patrick M. A., Liu, Yichuan, Hakonarson, Hakon, Rammah, Hayaal, Matrouk, Alia
Publicado 2022

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen

por Chen, Ruiqi, Liu, Xing, Law, Arjun D., Kanfar, Solaf, Maze, Dawn, Chan, Steven M., Gupta, Vikas, Yee, Karen W., Minden, Mark D., Schimmer, Aaron D., Schuh, Andre C., McNamara, Caroline J., Murphy, Tracy, Xu, Anna, Falcone, Umberto, Seki, Jack, Sibai, Hassan
Publicado 2020